CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market

Partnershippembrolizumab biosimilarPositive
AI Analysis

Summary

Orion Pharma announced an agreement with Qilu Pharma Europe for the development and distribution of a pembrolizumab biosimilar for the European market.

Importance:5/10
Sentiment:
0.30
partnershipbiosimilarpembrolizumabEurope
Related Companies

Read the original article

Published by GlobeNewswire Pharma on October 6, 2026 6:00 AM

Read Original